Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Radiation-induced thyroid cancer

Arthur B Schneider, MD, PhD
R Michael Tuttle, MD
Section Editors
David S Cooper, MD
Douglas S Ross, MD
Deputy Editor
Jean E Mulder, MD


Radiation exposure of the thyroid during childhood is the most clearly defined environmental factor associated with benign and malignant thyroid tumors. The risk of thyroid cancer following irradiation is related to radiation dose and age (greater for children exposed early in life), and the risk persists throughout life. Radiation exposure during childhood also increases the risk of benign thyroid nodules and hypothyroidism.

The purpose of this topic is to review the evaluation of a patient with a history of childhood radiation exposure and how such a history affects treatment of patients with thyroid tumors. Radiation injury to other organs is reviewed separately. (See "Biology and clinical features of radiation injury in adults" and "Treatment of radiation injury in the adult" and "Clinical features of radiation exposure in children" and "Management of radiation exposure in children following a nuclear disaster".)


Type of exposure — Radiation exposure may be external or internal.

External – The predominant types of external radiation are diagnostic radiographs, therapeutic radiation for the treatment of cancer, and historical use of external radiation to treat a wide variety of nonmalignant conditions. External radiation also includes brachytherapy, whereby a sealed radiation source is placed adjacent to a treatment area.

Internal – Internal radiation exposure includes ingestion of foods or liquids contaminated with radioactivity or by inhalation of radioactive gases or particles. Internal radiation occurs after exposure to nuclear fallout (from testing and accidents at operating nuclear power plants or above ground nuclear explosive testing) or after ingestion of radioiodine for diagnostic tests and for therapy of hyperthyroidism.


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jun 2017. | This topic last updated: Jun 28, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Lubin JH, Adams MJ, Shore R, et al. Thyroid cancer following childhood low dose radiation exposure: a pooled analysis of nine cohorts. J Clin Endocrinol Metab 2017.
  2. Veiga LH, Holmberg E, Anderson H, et al. Thyroid Cancer after Childhood Exposure to External Radiation: An Updated Pooled Analysis of 12 Studies. Radiat Res 2016; 185:473.
  3. Veiga LH, Lubin JH, Anderson H, et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat Res 2012; 178:365.
  4. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141:259.
  5. Furukawa K, Preston D, Funamoto S, et al. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. Int J Cancer 2013; 132:1222.
  6. Sinnott B, Ron E, Schneider AB. Exposing the thyroid to radiation: a review of its current extent, risks, and implications. Endocr Rev 2010; 31:756.
  7. Schonfeld SJ, Lee C, Berrington de González A. Medical exposure to radiation and thyroid cancer. Clin Oncol (R Coll Radiol) 2011; 23:244.
  8. Kleinerman RA. Cancer risks following diagnostic and therapeutic radiation exposure in children. Pediatr Radiol 2006; 36 Suppl 2:121.
  9. Land CE, Bouville A, Apostoaei I, Simon SL. Projected lifetime cancer risks from exposure to regional radioactive fallout in the Marshall Islands. Health Phys 2010; 99:201.
  10. Cardis E, Howe G, Ron E, et al. Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot 2006; 26:127.
  11. Suzuki S. Childhood and Adolescent Thyroid Cancer in Fukushima after the Fukushima Daiichi Nuclear Power Plant Accident: 5 Years On. Clin Oncol (R Coll Radiol) 2016; 28:263.
  12. Sadetzki S, Chetrit A, Lubina A, et al. Risk of thyroid cancer after childhood exposure to ionizing radiation for tinea capitis. J Clin Endocrinol Metab 2006; 91:4798.
  13. Davis S, Kopecky KJ, Hamilton TE, et al. Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site. JAMA 2004; 292:2600.
  14. Cardis E, Kesminiene A, Ivanov V, et al. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 2005; 97:724.
  15. Tronko MD, Howe GR, Bogdanova TI, et al. A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening. J Natl Cancer Inst 2006; 98:897.
  16. Zablotska LB, Ron E, Rozhko AV, et al. Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident. Br J Cancer 2011; 104:181.
  17. Hatch M, Brenner A, Bogdanova T, et al. A screening study of thyroid cancer and other thyroid diseases among individuals exposed in utero to iodine-131 from Chernobyl fallout. J Clin Endocrinol Metab 2009; 94:899.
  18. Brenner AV, Tronko MD, Hatch M, et al. I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect 2011; 119:933.
  19. Richardson DB. Exposure to ionizing radiation in adulthood and thyroid cancer incidence. Epidemiology 2009; 20:181.
  20. Hayashi Y, Lagarde F, Tsuda N, et al. Papillary microcarcinoma of the thyroid among atomic bomb survivors: tumor characteristics and radiation risk. Cancer 2010; 116:1646.
  21. Kesminiene A, Evrard AS, Ivanov VK, et al. Risk of thyroid cancer among chernobyl liquidators. Radiat Res 2012; 178:425.
  22. Davies SM. Subsequent malignant neoplasms in survivors of childhood cancer: Childhood Cancer Survivor Study (CCSS) studies. Pediatr Blood Cancer 2007; 48:727.
  23. Taylor AJ, Croft AP, Palace AM, et al. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study. Int J Cancer 2009; 125:2400.
  24. Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000; 85:3227.
  25. de Vathaire F, Haddy N, Allodji RS, et al. Thyroid Radiation Dose and Other Risk Factors of Thyroid Carcinoma Following Childhood Cancer. J Clin Endocrinol Metab 2015; 100:4282.
  26. Mostoufi-Moab S, Seidel K, Leisenring WM, et al. Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 2016; 34:3240.
  27. Reulen RC, Frobisher C, Winter DL, et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 2011; 305:2311.
  28. Rizzo JD, Curtis RE, Socié G, et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009; 113:1175.
  29. Nikiforova MN, Stringer JR, Blough R, et al. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 2000; 290:138.
  30. Klugbauer S, Lengfelder E, Demidchik EP, Rabes HM. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 1995; 11:2459.
  31. Nikiforov YE, Rowland JM, Bove KE, et al. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 1997; 57:1690.
  32. Bounacer A, Wicker R, Caillou B, et al. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 1997; 15:1263.
  33. Collins BJ, Chiappetta G, Schneider AB, et al. RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. J Clin Endocrinol Metab 2002; 87:3941.
  34. Nikiforova MN, Ciampi R, Salvatore G, et al. Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer Lett 2004; 209:1.
  35. Ciampi R, Knauf JA, Kerler R, et al. Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 2005; 115:94.
  36. Saad AG, Kumar S, Ron E, et al. Proliferative activity of human thyroid cells in various age groups and its correlation with the risk of thyroid cancer after radiation exposure. J Clin Endocrinol Metab 2006; 91:2672.
  37. Takahashi M, Saenko VA, Rogounovitch TI, et al. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 2010; 19:2516.
  38. Children's Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers, October 2013. http://www.survivorshipguidelines.org/pdf/LTFUGuidelines.pdf (Accessed on June 28, 2017).
  39. Schneider AB, Sarne DH. Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Nat Clin Pract Endocrinol Metab 2005; 1:82.
  40. Yeh H, Matanoski GM, Wang Ny, et al. Cancer incidence after childhood nasopharyngeal radium irradiation: a follow-up study in Washington County, Maryland. Am J Epidemiol 2001; 153:749.
  41. Ronckers CM, Van Leeuwen FE, Hayes RB, et al. Cancer incidence after nasopharyngeal radium irradiation. Epidemiology 2002; 13:552.
  42. Yasumura S, Hosoya M, Yamashita S, et al. Study protocol for the Fukushima Health Management Survey. J Epidemiol 2012; 22:375.
  43. Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys 1995; 31:1165.
  44. Francis GL, Waguespack SG, Bauer AJ, et al. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2015; 25:716.
  45. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26:1.
  46. Lando A, Holm K, Nysom K, et al. Serum thyroglobulin as a marker of thyroid neoplasms after childhood cancer. Acta Paediatr 2003; 92:1284.
  47. Momani MS, Shore-Freedman E, Collins BJ, et al. Familial concordance of thyroid and other head and neck tumors in an irradiated cohort: analysis of contributing factors. J Clin Endocrinol Metab 2004; 89:2185.
  48. Kovalchik SA, Ronckers CM, Veiga LH, et al. Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. J Clin Oncol 2013; 31:119.
  49. Schneider AB, Bekerman C, Leland J, et al. Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab 1997; 82:4020.
  50. Shimura H, Suzuki S, Fukushima T, et al. Prevalence of thyroid nodular lesions in children and adolescents. Fukushima J Med Sci 2014; 60:196.
  51. Hayashida N, Imaizumi M, Shimura H, et al. Thyroid ultrasound findings in a follow-up survey of children from three Japanese prefectures: Aomori, Yamanashi, and Nagasaki. Sci Rep 2015; 5:9046.
  52. Fukushima T, Suzuki S, Ohira T, et al. Prevalence of ectopic intrathyroidal thymus in Japan: the Fukushima health management survey. Thyroid 2015; 25:534.
  53. Ohira T, Takahashi H, Yasumura S, et al. Comparison of childhood thyroid cancer prevalence among 3 areas based on external radiation dose after the Fukushima Daiichi nuclear power plant accident: The Fukushima health management survey. Medicine (Baltimore) 2016; 95:e4472.
  54. Piccardo A, Foppiani L, Puntoni M, et al. Role of low-cost thyroid follow-up in children treated with radiotherapy for primary tumors at high risk of developing a second thyroid tumor. Q J Nucl Med Mol Imaging 2012; 56:459.
  55. Brignardello E, Felicetti F, Castiglione A, et al. Ultrasound surveillance for radiation-induced thyroid carcinoma in adult survivors of childhood cancer. Eur J Cancer 2016; 55:74.
  56. Clement SC, Kremer LC, Links TP, et al. Is outcome of differentiated thyroid carcinoma influenced by tumor stage at diagnosis? Cancer Treat Rev 2015; 41:9.
  57. Metzger ML, Howard SC, Hudson MM, et al. Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma. Pediatr Blood Cancer 2006; 46:314.
  58. Imaizumi M, Usa T, Tominaga T, et al. Long-term prognosis of thyroid nodule cases compared with nodule-free controls in atomic bomb survivors. J Clin Endocrinol Metab 2005; 90:5009.
  59. O'Kane P, Shelkovoy E, McConnell RJ, et al. Frequency of undetected thyroid nodules in a large I-131-exposed population repeatedly screened by ultrasonography: results from the Ukrainian-American cohort study of thyroid cancer and other thyroid diseases following the Chornobyl accident. Thyroid 2010; 20:959.
  60. Mihailescu DV, Schneider AB. Size, number, and distribution of thyroid nodules and the risk of malignancy in radiation-exposed patients who underwent surgery. J Clin Endocrinol Metab 2008; 93:2188.
  61. Hatipoglu BA, Gierlowski T, Shore-Freedman E, et al. Fine-needle aspiration of thyroid nodules in radiation-exposed patients. Thyroid 2000; 10:63.
  62. Nagataki S, Hirayu H, Izumi M, et al. High prevalence of thyroid nodule in area of radioactive fallout. Lancet 1989; 2:385.
  63. Schneider AB, Recant W, Pinsky SM, et al. Radiation-induced thyroid carcinoma. Clinical course and results of therapy in 296 patients. Ann Intern Med 1986; 105:405.
  64. Rubino C, Cailleux AF, Abbas M, et al. Characteristics of follicular cell-derived thyroid carcinomas occurring after external radiation exposure: results of a case control study nested in a cohort. Thyroid 2002; 12:299.
  65. Shaha MA, Wang LY, Migliacci JC, et al. Previous External Beam Radiation Treatment Exposure Does Not Confer Worse Outcome for Patients with Differentiated Thyroid Cancer. Thyroid 2017; 27:412.
  66. Nikiforov YE. Radiation-induced thyroid cancer: what we have learned from chernobyl. Endocr Pathol 2006; 17:307.
  67. Rumyantsev PO, Saenko VA, Ilyin AA, et al. Radiation exposure does not significantly contribute to the risk of recurrence of Chernobyl thyroid cancer. J Clin Endocrinol Metab 2011; 96:385.
  68. Tuttle RM, Vaisman F, Tronko MD. Clinical presentation and clinical outcomes in Chernobyl-related paediatric thyroid cancers: what do we know now? What can we expect in the future? Clin Oncol (R Coll Radiol) 2011; 23:268.
  69. Subbiah S, Collins BJ, Schneider AB. Factors related to the recurrence of thyroid nodules after surgery for benign radiation-related nodules. Thyroid 2007; 17:41.
  70. Zanzonico PB, Becker DV. Effects of time of administration and dietary iodine levels on potassium iodide (KI) blockade of thyroid irradiation by 131I from radioactive fallout. Health Phys 2000; 78:660.
  71. Nauman J, Wolff J. Iodide prophylaxis in Poland after the Chernobyl reactor accident: benefits and risks. Am J Med 1993; 94:524.
  72. Committee to Assess the Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. Distribution and administration of potassium iodide in the event of a nuclear incident. National Research Council of the National Academies. National Academies of Science, 2004.
  73. The Medical Letter 2002; 44:95.
  74. The Fukushima Daiichi Accident. International Atomic Energy Agency; 2015. Available online at http://www-pub.iaea.org/books/IAEABooks/10962/The-Fukushima-Daiichi-Accident (accessed September 8, 2015).
  75. Leung AM, Bauer AJ, Benvenga S, et al. American Thyroid Association Scientific Statement on the Use of Potassium Iodide Ingestion in a Nuclear Emergency. Thyroid 2017; 27:865.